Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 170.20
Bid: 170.20
Ask: 170.40
Change: -1.00 (-0.58%)
Spread: 0.20 (0.118%)
Open: 171.40
High: 173.00
Low: 170.00
Prev. Close: 171.20
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 May 2023 14:27

RNS Number : 8559A
Essentra plc
26 May 2023
 

Essentra plc (the "Company")

Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

The notification made on behalf of Persons Discharging Managerial Responsibility ('PDMRs') under article 19.1 of the UK Market Abuse Regulation ('MAR') relates to transactions made on behalf PDMRs, in the Company.

On 31 March 2023, awards granted in 2020 under the Company's Deferred Annual Share Bonus Plan vested in full for two PDMRs.

The Company has been advised that some of the shares released to the PDMRs were subsequently disposed of on 31 March 2023, as indicated below at a share price of £1.922.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Scott Fawcett

Oshin Cassidy

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

 

Scott Fawcett

CEO

Oshin Cassidy

Group HR Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Essentra plc

b)

 

LEI

 

 

5493007MOZNA03BVNE96

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares

Identification code

GB00B0744359

 

 

b)

 

Nature of the transaction

 

Vesting of awards granted on 30 March 2020 under the Deferred Annual Share Bonus Plan and sale of resulting shares to cover the tax liability due on the vesting.

 

 

c)

Price(s) and volume(s)

Name

Vesting Date

Price (£)

Shares vested

Shares sold to cover tax liability

Balance of shares to be retained

Scott Fawcett

March 2023

 

£1.922

9,586

4,325

5,261

Oshin Cassidy

March 2023

 

£1.922

8,553

3,860

4,693

d)

 

Aggregated information

- Aggregated volume

8,185

- Price

1.922

e)

 

Date of the transaction

 

31 March 2023

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

Enquiries

 

Emma Reid

Company Secretary

T: 01908 359100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUCPAUPWGWQ
Date   Source Headline
20th Apr 20173:03 pmRNSDirector/PDMR Shareholding
20th Apr 20177:01 amRNSTrading Update
3rd Apr 20178:45 amRNSHolding(s) in Company
3rd Apr 20178:40 amRNSTotal Voting Rights
17th Mar 20173:22 pmRNSNotice of AGM
14th Mar 20174:07 pmRNSHolding(s) in Company
13th Mar 20175:53 pmRNSHolding(s) in Company
8th Mar 201710:00 amRNSDirector/PDMR Shareholding
6th Mar 20171:00 pmRNSCompletion of Divestment of Porous Technologies
3rd Mar 20175:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20172:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20179:52 amRNSDirector/PDMR Shareholding
3rd Mar 20178:53 amRNSDirector/PDMR Shareholding
3rd Mar 20177:00 amRNSDirector/PDMR Shareholding
2nd Mar 20176:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20176:03 pmRNSDirector/PDMR Shareholding
2nd Mar 20175:50 pmRNSDirector/PDMR Shareholding
2nd Mar 20175:26 pmRNSTotal Voting Rights
1st Mar 20173:45 pmRNSDirector/PDMR Shareholding
27th Feb 201710:55 amRNSHolding(s) in Company
27th Feb 201710:14 amRNSHolding(s) in Company
22nd Feb 20175:00 pmRNSHolding(s) in Company
21st Feb 20174:34 pmRNSDirector/PDMR Shareholding
20th Feb 20175:53 pmRNSHolding(s) in Company
20th Feb 20172:45 pmRNSDirector/PDMR Shareholding
17th Feb 20177:08 amRNSFinal Results
10th Feb 20174:38 pmRNSInvitation to Full Year 2016 Results Webcast
10th Feb 20172:01 pmRNSHolding(s) in Company
1st Feb 20178:50 amRNSTotal Voting Rights
24th Jan 201712:59 pmRNSHolding(s) in Company
23rd Jan 20177:01 amRNSTrading Statement
20th Jan 20174:46 pmRNSHolding(s) in Company
20th Jan 201710:26 amRNSHolding(s) in Company
4th Jan 20174:55 pmRNSExecutive Director Appointment
3rd Jan 20172:21 pmRNSTotal Voting Rights
30th Dec 20168:58 amRNSDirector/PDMR Shareholding
23rd Dec 20163:21 pmRNSDirector/PDMR Shareholding
16th Dec 20164:03 pmRNSDirector/PDMR Shareholding
12th Dec 20163:56 pmRNSShare Transaction
6th Dec 201612:52 pmRNSPeter Hill - External Appointment
6th Dec 20167:49 amRNSTotal Voting Rights
21st Nov 201610:53 amRNSHolding(s) in Company
21st Nov 20167:03 amRNSTrading Statement
7th Nov 20164:43 pmRNSDirector/PDMR Shareholding
7th Nov 20162:17 pmRNSDirector/PDMR Shareholding
4th Nov 20166:00 pmRNSHolding(s) in Company
3rd Nov 20162:46 pmRNSProposed Appointment of External Auditor
2nd Nov 20163:58 pmRNSDirector/PDMR Shareholding
1st Nov 201611:37 amRNSTotal Voting Rights
31st Oct 20167:01 amRNSAppointment of New Chief Executive

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.